# ImmunityBio, Inc.: Form 8-K, filed Oct 26, 2020

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2020-10-26
- Accepted by EDGAR: Oct 26, 2020, 17:05 ET
- Period: 2020-10-26
- Accession: 0001193125-20-277062
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000119312520277062/d39325d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000119312520277062/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000119312520277062/d39325d8k.htm

Filed Oct 26, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-277062. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.
